发明名称 |
High Osteocalcin Microcrystalline Hydroxyapatite For Calcium Supplement |
摘要 |
An improved manufacturing process produces microcrystalline hydroxyapatrte with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products. |
申请公布号 |
US2016228517(A1) |
申请公布日期 |
2016.08.11 |
申请号 |
US201414916695 |
申请日期 |
2014.09.04 |
申请人 |
WAITAKI BIOSCIENCES |
发明人 |
McIntosh Craig Lachlan;Finderup Susan;Garthwaite Harold |
分类号 |
A61K38/39;A61K9/14;A61K33/42 |
主分类号 |
A61K38/39 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for producing a high osteocalcin microcrystalline hydroxyapatite preparation without using organic solvents to remove fat comprising the steps of:
selecting bovine leg bone diaphysis; reducing the bovine leg bone to a predetermined particle size; digesting the reduced bovine leg bone with a protease under temperature controlled conditions, thereby removing fat; drying the digested bovine leg bone; and milling the digested leg bone to produce high osteocalcin microcrystalline hydroxyapatite with a predetermined particle size distribution, wherein the high osteocalcin microcrystalline hydroxyapatite does not cause elevation of ionized blood calcium levels when administered as a dietary supplement. |
地址 |
Christchurch NZ |